Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.445, 2004-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HAART introduction in Italy provides cost, QOL advantage
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :
Access to resources
Recommend
QOL advantage with sildenafil for erectile dysfunction
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 347, 2002-01 ,pp. :
Intermittent HAART no better than continuous for QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. :
QOL in HIV infections enhanced with 12 months of HAART
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 400, 2003-01 ,pp. :
HAART provides protective effects against anaemia
Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. :